ClinicalTrials.gg
Sign In
WithdrawnNCT00792415Updated Feb 11, 2025

Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

An observational study in Substance Withdrawal Syndrome, sponsored by Banner Health. Withdrawn at 1 site in United States. Open to participants aged 2 Weeks to 18 Years. Per ClinicalTrials.gov, last updated 2025-02-11.

Sponsored by Banner Health · Observational

Why this study was withdrawn
Study doctor no longer with Banner Health, please remove this study from our list.
Study type
Observational
Model
Other
Time perspective
Other
Enrollment
0
Ages
2 Weeks to 18 Years
Sex
All
01

Study summary

The purpose of this study is to assess the validity and reliability of an abstinence syndrome assessment tool used in pediatric patients with iatrogenic opioid dependence.

Read the detailed description

None available.

02

Conditions studied

  • Substance Withdrawal Syndrome

Keywords

  • Abstinence syndrome symptoms
  • Withdrawal symptoms
  • Opioid dependence
03

In context

Substance Withdrawal Syndrome

131 studies on the registry are indexed under Substance Withdrawal Syndrome; 8 are open to participants now.

Browse Substance Withdrawal Syndrome studies →

Lead sponsor

Banner Health is the lead sponsor of 19 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Weeks to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric Intensive Care Unit patients

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pediatric Intensive Care Unit patients ages 2 weeks to 18 years
  • Patients receiving continuous opioid infusions for 5 days (at least 120 hours) or more

Exclusion criteria

Exclusion Criteria:

  • Attending discretion
  • Patients with deterioration of medical status requiring interventions of pain control, surgery, sedation, or re-intubation
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
0 participants (actual)
06

What researchers measure

Primary outcomes

  1. Total scores of abstinence syndrome symptoms

    None available - PI no longer with Banner

    Time frame: Up to 23 days

Secondary outcomes

  1. Expert opinion on abstinence syndrome

    None available - PI no longer with Banner

    Time frame: Up to 23 days

07

Study locations

1 site
  • Cardon Children's Medical Center
    Mesa, Arizona 85202, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2009, a primary completion of Apr 2010 and a completion of Dec 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2008
First posted
Nov 18, 2008
Start
Nov 2009
Primary completionEst.
Apr 2010
CompletionEst.
Dec 2010
Last update
Feb 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00792415
Lead sponsor
Banner Health
Responsible party
Sponsor
First posted
Nov 18, 2008
Start date
Nov 2009
Primary completion
Apr 2010 (estimated)
Completion
Dec 2010 (estimated)
Last update
Feb 11, 2025

Study contacts

Teri Reyburn-Orne, RN, MSN, PNP
principal investigator · Banner Children's Hospital at Banner Desert Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Substance Withdrawal Syndrome →

Other studies from this sponsor

Banner Health

Start the discussion